PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
23.90%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
30.00%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
23.13%
Similar gross profit growth to CRWV's 25.15%. Walter Schloss would investigate industry dynamics.
-0.62%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
9.17%
R&D change of 9.17% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.82%
Operating expenses growth 50-75% of CRWV's 17.97%. Bruce Berkowitz would examine efficiency.
15.87%
Similar total costs growth to CRWV's 18.28%. Walter Schloss would investigate norms.
No Data
No Data available this quarter, please select a different quarter.
-1.12%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
29.41%
Similar EBITDA growth to CRWV's 33.05%. Walter Schloss would investigate industry trends.
15.10%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
32.04%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
6.57%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
-28.27%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
21.89%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
-1.62%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
30.24%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
17.83%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
-4.90%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
17.65%
Similar EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
12.50%
Diluted EPS growth 50-75% of CRWV's 23.08%. Martin Whitman would scrutinize operations.
1.39%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
1.52%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.